Esmolol

Class Beta blocker
Chemistry

aryloxypropanolamine

Routes of administration

IV

Absorption

0% oral bioavailability

Solubility

pKa 9.5, minimal lipid solubility

Distribution

VOD 3.4 L/kg; 60% protein bound

Metabolism

rapidly metabolized in blood by hydrolysis of its methyl ester linkag

Elimination

minimal renal excretion; half-life 9 min

Time course of action

Rapid onset and offset of effect

Target receptor

Highly selective β1 receptor blocker

Mechanism of action

By binding to Gs-protein coupled β1 receptors, blocks cAMP synthesis

Clinical effects

β1 effects: decreased heart rate, cdecreased contractility, decreased blood pressure, lower myocardial oxygen demand and increased diastolci coronary fillng, and decreased arrhythmogenicity.

Literature reference

Oliver et al (2019)

CICM details of understanding Level 2
Mentioned around Deranged Physiology
Related SAQs

Question 5 from the first paper of 2022 (labetalol vs. esmolol)

Question 14 from the second paper of 2019 (metoprolol vs esmolol)